Prevention or reversal of levodopa-induced cardiac arrhythmias by decarboxylase inhibitors.
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000188:drug therapy / Q000517:prevention & control; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002395:Catecholamines / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage; D004285:Dogs; D004562:Electrocardiography; D006221:Halothane; D006834:Hydrazines / Q000037:antagonists & inhibitors; D007275:Injections, Intravenous; D007668:Kidney / Q000378:metabolism; D007773:Lactates / Q000037:antagonists & inhibitors; D009206:Myocardium / Q000378:metabolism; D014316:Tritium
D002395:Catecholamines; D006834:Hydrazines; D007773:Lactates; D014316:Tritium; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases; D006221:Halothane